FI872096A - Foerhoejd expression av humant interleukin-2 i daeggdjursceller. - Google Patents

Foerhoejd expression av humant interleukin-2 i daeggdjursceller. Download PDF

Info

Publication number
FI872096A
FI872096A FI872096A FI872096A FI872096A FI 872096 A FI872096 A FI 872096A FI 872096 A FI872096 A FI 872096A FI 872096 A FI872096 A FI 872096A FI 872096 A FI872096 A FI 872096A
Authority
FI
Finland
Prior art keywords
foerhoejd
daeggdjursceller
humant
interleukin
expression
Prior art date
Application number
FI872096A
Other languages
English (en)
Finnish (fi)
Other versions
FI872096A0 (fi
Inventor
Bryan Richard Cullen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI872096A0 publication Critical patent/FI872096A0/fi
Publication of FI872096A publication Critical patent/FI872096A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/108Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI872096A 1986-05-12 1987-05-12 Foerhoejd expression av humant interleukin-2 i daeggdjursceller. FI872096A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/862,082 US4992367A (en) 1986-05-12 1986-05-12 Enhanced expression of human interleukin-2 in mammalian cells

Publications (2)

Publication Number Publication Date
FI872096A0 FI872096A0 (fi) 1987-05-12
FI872096A true FI872096A (fi) 1987-11-13

Family

ID=25337602

Family Applications (1)

Application Number Title Priority Date Filing Date
FI872096A FI872096A (fi) 1986-05-12 1987-05-12 Foerhoejd expression av humant interleukin-2 i daeggdjursceller.

Country Status (25)

Country Link
US (1) US4992367A (sv)
JP (1) JPS62278994A (sv)
AR (1) AR241794A1 (sv)
AT (1) AT389892B (sv)
AU (1) AU603576B2 (sv)
BE (1) BE1000717A5 (sv)
CH (1) CH675731A5 (sv)
DE (1) DE3715808A1 (sv)
DK (1) DK234087A (sv)
ES (2) ES2006476A6 (sv)
FI (1) FI872096A (sv)
FR (1) FR2598433B1 (sv)
GB (1) GB2190382B (sv)
GR (1) GR870727B (sv)
HU (1) HU205384B (sv)
IL (1) IL82475A0 (sv)
IT (1) IT1215478B (sv)
LU (1) LU86874A1 (sv)
MC (1) MC1821A1 (sv)
NL (1) NL8701132A (sv)
NO (1) NO871939L (sv)
NZ (1) NZ220246A (sv)
PT (1) PT84849B (sv)
SE (1) SE8701934L (sv)
ZA (1) ZA872768B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (ja) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
FR2636231A1 (fr) * 1988-09-09 1990-03-16 Sanofi Sa Cellules eucaryotes recombinees productrices d'interleukine-1 (beta) mature n-glycosylee, procede et vecteurs necessaires pour leur obtention et procede d'obtention d'interleukine-1 (beta) mature n-glycosylee
WO1990010069A1 (en) * 1989-02-28 1990-09-07 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr RECOMBINANT PLASMID DNA pAA 1213-23 AND pAC 262-33 CODING FOR SYNTHESIS OF HUMAN INTERLEUKIN-2, METHOD OF THEIR CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI RRI/pAC 262-33 AS PRODUCER OF HUMAN INTERLEUKIN-2
IL95330A0 (en) * 1989-08-11 1991-06-30 Lilly Co Eli Expression of a functional insect specific toxin gene in mammalian cells
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
US5856178A (en) * 1993-08-30 1999-01-05 Utah State University DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
US5548075A (en) * 1993-08-30 1996-08-20 Utah State University DNA cassette and transgenic organisms carrying lytic peptide-encoding genes
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
CN1200037A (zh) 1995-10-17 1998-11-25 韦恩州立大学 鸡白细胞介素-15及其用途
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
AUPP655698A0 (en) * 1998-10-16 1998-11-05 Commonwealth Scientific And Industrial Research Organisation Delivery system for porcine somatotropin
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
KR20020043448A (ko) * 2000-12-04 2002-06-10 리송알렉스인근 인터루킨-2 재조합 단백질 및 그의 제조방법
US20040071671A1 (en) * 2001-02-20 2004-04-15 Leturcq Didier J. Cell therapy method for the treatment of tumors
JP2006510567A (ja) * 2001-02-20 2006-03-30 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 腫瘍の治療のための細胞治療方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
AU556353B2 (en) * 1982-12-15 1986-10-30 Ajinomoto Co., Inc. Interleukin-2 polypeptide
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
IL71275A0 (en) * 1983-03-21 1984-06-29 Sparamedica Ag Human interleukin-2-and its preparation
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
EP0162898A4 (en) * 1983-11-14 1987-07-23 Chiron Corp INTERLEUKIN-2 GENERATION USING CLONED GENES FOR INTERLEUKIN-2 AND YEAR ALPHA FACTOR.
FR2559782B1 (fr) * 1984-02-16 1986-07-18 Transgene Sa Vecteur d'expression dans les levures de l'interleukine-2, levures transformees et procede de preparation de l'interleukine-2
EP0163603B1 (en) * 1984-05-08 1989-12-13 Genetics Institute, Inc. A human t-cell growth factor
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
EP0172619A1 (en) * 1984-06-20 1986-02-26 Takeda Chemical Industries, Ltd. Novel transformant and use thereof
CA1275954C (en) * 1984-08-31 1990-11-06 Hing Cheug Wong 3'-expression enhancing fragments and method
FR2583770B1 (fr) * 1985-06-21 1988-08-19 Transgene Sa Expression de l'il-2 humaine dans les cellules de mammiferes par un poxvirus recombine
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices

Also Published As

Publication number Publication date
GB2190382A (en) 1987-11-18
HU205384B (en) 1992-04-28
SE8701934L (sv) 1987-11-13
IL82475A0 (en) 1987-11-30
HUT45558A (en) 1988-07-28
ZA872768B (en) 1988-04-27
ES2006476A6 (es) 1989-05-01
IT8720479A0 (it) 1987-05-12
DK234087A (da) 1987-11-13
GB2190382B (en) 1990-08-15
BE1000717A5 (fr) 1989-03-21
DK234087D0 (da) 1987-05-08
IT1215478B (it) 1990-02-14
JPS62278994A (ja) 1987-12-03
ATA263787A (de) 1989-07-15
AU7270387A (en) 1987-11-19
CH675731A5 (sv) 1990-10-31
AR241794A1 (es) 1992-12-30
SE8701934D0 (sv) 1987-05-11
NO871939D0 (no) 1987-05-11
LU86874A1 (fr) 1988-06-13
NO871939L (no) 1987-11-13
GR870727B (en) 1987-09-21
US4992367A (en) 1991-02-12
PT84849B (pt) 1990-02-08
MC1821A1 (fr) 1988-03-18
FR2598433A1 (fr) 1987-11-13
GB8711072D0 (en) 1987-06-17
NL8701132A (nl) 1987-12-01
AT389892B (de) 1990-02-12
DE3715808A1 (de) 1987-12-10
NZ220246A (en) 1990-07-26
FR2598433B1 (fr) 1990-09-21
AU603576B2 (en) 1990-11-22
ES2012940A6 (es) 1990-04-16
PT84849A (pt) 1987-06-01
FI872096A0 (fi) 1987-05-12

Similar Documents

Publication Publication Date Title
FI890799A0 (fi) Fjaerrprogrammering av kanalauktoriseringsenhet i kabeltelevision.
FI870792A0 (fi) Foerfarande foer tillsaettande av aromaemnen i tobak.
FI875512A0 (fi) Anordning foer tillvaratagande av vaerme fraon avloppsluften i torkpartiet av en pappersmaskin.
FI872470A (fi) Inducering av galaktosregulerad genexpression i jaest.
FI872096A0 (fi) Foerhoejd expression av humant interleukin-2 i daeggdjursceller.
FI870922A (fi) Foerfarande foer paovisning av polynukleotidsekvenser medelst enkelhybridisering i loesningsfas.
FI865073A0 (fi) Foerfarande foer eliminering av mikrober i processvatten av pappersfabriker.
FI873693A0 (fi) Foerfarande foer initiering av kopplingsfunktion i en programmerbar mottagaranordning av en underhaollningselektronik.
FI875193A (fi) Foerfarande foer framstaellning av homo- och kopolymerer av vinylklorid i en ympad mikrosuspension.
FI890973A0 (fi) Anordning foer reversering av luftfloede i en torkkammare.
FI881491A (fi) Foerfarande foer inducering av sekundaer metabolitproduktion i vaextkulturer.
FI860669A0 (fi) Spetslist i inloppslaodan av en pappersmaskin.
FI871455A (fi) Foerfarande foer framstaellning av vinylkloridhomo- och kopolymerlatexer i mikrosuspension foer anvaendning saosom froeaemnen.
FI77942B (fi) Anordning foer stabilisering av maetningsgeometri i en analysator.
FI861927A0 (fi) Laosmekanism foer styranordningen i en elbrytare.
FI870238A0 (fi) Utdragsanordning foer hantering av i upprullningsmaskiner insatta upprullningsroer.
FI872865A0 (fi) Kopplingsanordning foer aotskiljning av ledarna i en abonnentanslutning fraon matningsspaenningen.
FI860065A (fi) Foerfarande foer fastsvetsning av en stoedprofil i en mellanvaegg.
FI906152A0 (fi) Anordning foer insaettning av en rullhylsa i en rullmaskin.
FI862862A0 (fi) Anordning foer foerpackning av styckegods i en laoda.
FI862504A0 (fi) Foerfarande foer dosering av kemikalier i fibermassa.
FI863927A0 (fi) Foerfarande foer installering av tillaeggskonstruktioner i fordon.
FI861160A0 (fi) Tvaettningsfoerfarande foer tvaettning av blodiga redskap i tvaettmaskin.
FI860337A0 (fi) Hybridfoerfarande och -anordning foer utnyttjande av solenergi i byggnaders uppvaermning.
FI860294A0 (fi) Foerfarande foer minskning av restkolhalten i flygaska.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE AG